UnitedHealth Group Inc. (0R0O)
LSE
372.40
-9.15 (-2.40%)
Closed
Oct 8, 2026
Day's Range
368.50377.92
52 wk Range
255.98461.00
Financial Statements - 0R0O - UnitedHealth Group Inc.
Revenue
447.56B▲ 11.8%
Net Income
12.80B▼ 16.0%Net Margin 2.9%
EBITDA
23.32B▼ 35.9%
Free Cash Flow
16.07B▼ 22.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 447.56B | 400.27B | 367.53B | 322.13B | 285.27B | 255.63B |
| Cost of Goods | 364.65B | 310.87B | 280.66B | 244.54B | 217.94B | 190.14B |
| Gross Profit | 82.91B | 89.39B | 86.86B | 77.58B | 67.32B | 65.49B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 18.96B | 32.28B | 28.26B | 26.40B | 21.64B | 20.90B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -265M | -8.31B | 4.08B | 2.03B | 2.32B | 1.50B |
| Pre Tax Income | 14.69B | 20.07B | 29.11B | 26.34B | 22.31B | 20.74B |
| Income Tax | 1.89B | 4.82B | 5.96B | 5.70B | 4.57B | 4.97B |
| Net Income | 12.80B | 15.24B | 23.14B | 20.63B | 17.73B | 15.76B |
| EPS Basic | 13.309214 | 15.743169 | 24.12 | 21.541756 | 18.33 | 16.282241 |
| EPS Diluted | 13.23 | 15.51 | 23.86 | 21.18 | 18.08 | 16.03 |
| Basic Shares Outstanding | 905.83M | 915M | 928M | 934M | 943M | 946M |
| Diluted Shares Outstanding | 905.83M | 915M | 928M | 934M | 943M | 946M |
| Ebit | 18.69B | 23.97B | 32.35B | 28.43B | 23.97B | 22.40B |
| Ebitda | 23.32B | 36.38B | 32.24B | 29.80B | 24.74B | 23.79B |
| Net Income Continuous Operations | 12.80B | 15.24B | 23.14B | 20.63B | 17.73B | 15.76B |
| Minority Interests | -751M | -837M | -763M | -519M | -447M | -366M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
